New Brunswick, New Jersey (PRWEB) September 11, 2014
Rutgers University’s Center for Dermal Research will host its annual Innovations in Dermatological Sciences conference Oct. 8 in New Brunswick. The meeting will focus on how the university, industry and government sectors can collaborate to translate cutting-edge dermatological research into clinical use.
This conference is unique in bringing together experts who have had experience with cross-sector collaboration, to share their successes, best-practices, and lessons learned. Among the speakers scheduled will be Alice Gottlieb, M.D., chair of the Department of Dermatology at Tufts Medical Center, who contributed to the development of Remicade, a psoriasis treatment that is one of the world’s best-selling drugs.
Charles Biebylski, Ph.D., of the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS) will speak about the NCAT’s cooperative research and technology development experiences with industry. Also scheduled to present are experts from Allergan, Galderma, Glaxo Smith Kline and other companies, plus scientists with Rutgers, U-C Santa Barbara and the University of Maryland.
William Ju, M.D., president of Advancing Innovation in Dermatology Inc., a non-profit organization that participated in the conference planning, said: “We very much look forward to this year’s meeting. The conference will bring together people and organizations who by partnering can significantly catalyze product innovation in dermatology.”
The conference’s organizer is Bozena B. Michniak-Kohn, Ph.D, professor of pharmaceutics in Rutgers’ Ernest Mario School of Pharmacy and director of the Center for Dermal Research.
“This conference provides unique perspectives regarding the translation of basic dermatological research to successful products in the clinic,” Michniak-Kohn said. “We anticipate that both industry researchers and university scientists will be interested in this meeting, which is particularly attractive in this region given the prominence of the pharmaceutical industry.”
This conference will provide an opportunity for researchers from universities, industry and government to exhibit their works-in-progress and obtain feedback from their peers in an informal setting. The exhibits give attendees a forum where they can interactively learn about cutting-edge research projects, including information that may not yet have been published.
Scheduled speakers include:
- Christopher J. Molloy, Ph.D., R.Ph., senior vice president for research and economic development, Rutgers
- Alice Gottlieb, Ph.D., chair of the department of dermatology, Tufts University Medical Center
- Peter Nicholson, MBA, senior director of business development, Galderma S.A.
- Kathleen Carroll, Ph.D., associate director, Technology Transfer Center, National Cancer Institute
- Samir Mitragotri, Ph.D., professor of chemical engineering and director, Center for Bioengineering, University of California Santa Barbara
- Audra L. Stinchcomb, Ph.D., professor, University of Maryland School of Pharmacy, and chief scientific officer and founder of AllTranz
- Gupreet Ahluwalia, Ph.D., senior director, dermatology clinical R&D, Allergan
- Terry Robinson, M.A., executive director, Catalent Applied Drug Delivery Institute
- Andrea Epperly, Ph.D., director, business development & licensing, Stiefel Labs, a GSK company
- Michael Davitz, M.D., J.D., principal, Ascenda Law Group, PC
The agenda and online registration are on the Center for Dermal Research website. The conference is being held in partnership with the 12th biennial New Jersey Symposium on Biomaterials Science (njbiomaterials.org/biomaterials-symposia.htm), Oct. 6-7. Both are being held in the Heldrich Hotel.
About Rutgers – Established in 1766, Rutgers, The State University of New Jersey, is America’s eighth oldest institution of higher learning and one of the nation’s premier public research universities, educating more than 65,000 students. Rutgers’ flagship, based in New Brunswick, is the only public institution in New Jersey represented in the prestigious Association of American Universities. Rutgers is a member of the Big Ten Conference and its academic counterpart, the Committee on Institutional Cooperation – a consortium of 15 world-class research universities. Rutgers ranks #1 among U.S. universities for chemistry R&D funding. The Office of Research and Economic Development provides a central point for industry to access Rutgers, including a new website, businessportal.rutgers.edu